Table 4.
Patient demographics
| Total group (n = 34) | Study completers (n = 23) | Study discontinuers (n = 11) | |
|---|---|---|---|
| Age (years) | 50.7 ± 11.6 | 52.5 ± 7.9 | 46.9 ± 16.8 |
| Gender distribution | |||
| Females | 28 | 14 | 9 |
| Males | 11 | 5 | 6 |
| BMI (kg/m2) | 30.1 ± 5.4 | 30.7 ± 5.0 | 28.9 ± 6.4 |
| Race distribution | |||
| Caucasian | 31 | 20 | 11 |
| African-American | 3 | 3 | 0 |
| Morphine equivalents (mEq) | 390.1 ± 338.1 | 399.5 ± 264.4 | 370.3 ± 472.0 |
| Min | 100 | 100 | 100 |
| Max | 1700 | 812.5 | 1700 |
Major diagnoses included arthritis, back/spine/neck injury, chronic pain secondary to a medical or neurological condition, and headaches/migraines. There were no differences in the demographics between those participants who completed and those who discontinued the study (age: p = 0.32; BMI: p = 0.43; mEq: p = 0.85)